Last updated: Oct 19, 2026, 12:00 AM

A2A S.p.A Exchange (MI, EUR)

A2A.MI

-
-0.03 (-1.28%)
UtilitiesUtilities - Diversified
Invest Today
Invest Today
1 year return (CAGR)
10.35%
3 year return (CAGR)
21.17%
5 year return (CAGR)
11.56%
10 year return (CAGR)
8.31%
Stock Analysis

Adobe 2026 Q3 – Is sentiment driving the price?

Read More
Marketcap
7.70B
Price/Sales
0.37
Ent value
-
Price/Book
-
Div yield
0.00%
Growth years
-
Div growth
-
FCF payout
0.00%
Trailing P/E
6.35
PEG
-
Forward P/E
11.30
EPS growth
-

Stock information

iO Charts Blog

What is a stock exchange? Operation, actors, examples

Read More

Stock chart

No data
Stock price data
Open2.48
Daily high2.48
Daily low2.42
Daily Volume22.2M
1y analyst estimate2.61
Beta0.94
EPS (TTM)0.39
Dividend per share0.00
Ex-div date20 May 2025
Next earnings date17 Mar 2026

Ready to capitalize on A2A S.p.A's growth potential?

Take the next step in your portfolio.

Invest Today

Downside potential

Loading...
Downside potential data
A2A.MIS&P500
Current price drop from All-time high-70.16%-1.98%
Highest price drop-96.50%-56.47%
Date of highest drop24 Jul 20129 Mar 2009
Avg drop from high-76.21%-10.64%
Avg time to new high117 days12 days
Max time to new high6580 days1805 days
News
A2A SpA (AEMMF) offsets weaker hydro production and higher concession fees with resilient distribution and retail results, confirming 2026 guidance despite a 3% EBITDA decline.
November 10, 2026
14:30 London, 16:30 Helsinki, 11 November 2026 - Afarak Group SE ("Afarak" or "the Company") (LSE: AFRK, NASDAQ: AFAGR) AFARAK GROUP SE: CEO GUY KONSBRUCK TO STEP DOWN ON 30 JUNE 2027 Stock Exchange R...
November 11, 2026
Boost ROI through single-use bioreactors, automation, continuous processing, advanced purification, strategic partnerships and tariff-aware sourcing.Dublin, Nov. 11, 2026 (GLOBE NEWSWIRE) -- "Viral Ve...
November 11, 2026
LONDON, November 11, 2026-- Funds
November 11, 2026
PALO ALTO, Calif., Nov. 11, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) ("BridgeBio" or the "Company"), a commercial-stage, multi-product biopharmaceutical company focused on develo...
November 11, 2026
Aeon has seen its share price move sharply this year, which raises a straightforward question for anyone looking at the stock today. Do the current earnings of Aeon make its latest price tag look sens...
November 11, 2026
Nisshinbo Holdings has had a strong five year share price run, and after a recent pullback the question is whether the current valuation can still be explained by the cash the business is expected to ...
November 11, 2026
Mayr-Melnhof Karton has seen its share price move around sharply in recent years, and the recent rebound now puts the focus squarely on what its cash flows really justify. With the stock changing hand...
November 11, 2026
Nissan Chemical has had a sharp share price swing over the past year, which raises a straightforward question for you as an investor: Is the current ¥6,884 price tag adequately backed by the cash flow...
November 11, 2026
Leopalace21 has delivered very strong share price gains over the past few years, which naturally raises the question of whether today's ¥988 level is supported by the cash the business can generate. R...
November 11, 2026